IPA-targeted adoptive immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IPA-targeted adoptive immunotherapy, covering 2024-02-13 to 2024-02-13. Get the full timeline:
Most recent: Clinical Trial Update: IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia [Phase 2]